6929 Stock Overview
We Can Medicines Co., Ltd. operates a chain of drugstores in Taiwan.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
We Can Medicines Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$72.00 |
| 52 Week High | NT$194.50 |
| 52 Week Low | NT$71.10 |
| Beta | 0 |
| 1 Month Change | -7.57% |
| 3 Month Change | -27.64% |
| 1 Year Change | -61.50% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 56.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6929 | TW Consumer Retailing | TW Market | |
|---|---|---|---|
| 7D | 0% | -0.5% | 1.3% |
| 1Y | -61.5% | -5.5% | 29.2% |
Return vs Industry: 6929 underperformed the TW Consumer Retailing industry which returned -5.5% over the past year.
Return vs Market: 6929 underperformed the TW Market which returned 29.2% over the past year.
Price Volatility
| 6929 volatility | |
|---|---|
| 6929 Average Weekly Movement | 8.9% |
| Consumer Retailing Industry Average Movement | 3.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in TW Market | 8.7% |
| 10% least volatile stocks in TW Market | 2.3% |
Stable Share Price: 6929's share price has been volatile over the past 3 months.
Volatility Over Time: 6929's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of TW stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 993 | n/a | www.yourchance.com.tw |
We Can Medicines Co., Ltd. operates a chain of drugstores in Taiwan. The company offers medicine, health food, maternal and infant product, and medical equipment. It sells its products under the VITALPLUS and Sapporo brands.
We Can Medicines Co., Ltd. Fundamentals Summary
| 6929 fundamental statistics | |
|---|---|
| Market cap | NT$3.19b |
| Earnings (TTM) | NT$14.80m |
| Revenue (TTM) | NT$3.12b |
215.3x
P/E Ratio1.0x
P/S RatioIs 6929 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6929 income statement (TTM) | |
|---|---|
| Revenue | NT$3.12b |
| Cost of Revenue | NT$2.11b |
| Gross Profit | NT$1.01b |
| Other Expenses | NT$999.59m |
| Earnings | NT$14.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.33 |
| Gross Margin | 32.48% |
| Net Profit Margin | 0.47% |
| Debt/Equity Ratio | 34.3% |
How did 6929 perform over the long term?
See historical performance and comparison